Caspase Activity and Apoptosis Inhibitor 1 (CAAP1) (Middle Region) antibody
Quick Overview for Caspase Activity and Apoptosis Inhibitor 1 (CAAP1) (Middle Region) antibody (ABIN5517860)
Target
See all Caspase Activity and Apoptosis Inhibitor 1 (CAAP1) productsReactivity
Host
Clonality
Application
-
-
Binding Specificity
- Middle Region
-
Sequence
- GSVSCCGNAN FSGSVTGGGS GGSCWGGSSV ERSERRKRRS TDSSSVSGSL
-
Purification
- Affinity purified
-
Immunogen
- The immunogen is a synthetic peptide directed towards the middle region of human CAAP1
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Liquid. Purified antibody supplied in 1x PBS buffer with 0.09 % (w/v) sodium azide and 23 % sucrose.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- For short term use, store at 2-8°C up to 1 week. For long term storage, store at -20°C in small aliquots to prevent freeze-thaw cycles.
-
-
- Caspase Activity and Apoptosis Inhibitor 1 (CAAP1)
-
Alternative Name
- CAAP1
-
Background
-
Alias Symbols: CAAP, C9orf82
Protein Size: 361 -
Gene ID
- 79886
-
NCBI Accession
- NM_001167575, NP_001161047
-
UniProt
- Q9H8G2
Target
-